science
Hosted by Andy Marshall · science · EN-US
Two lapsed Nature editors, Andy Marshall and Juan-Carlos Lopez, have a conversation and a cocktail with experts in translational research and biomedicine
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
20%
Guest openness
Selective
Sign up to generate a grounded pitch for The Translational Mixer.
Signup to Generate a PitchTwo lapsed Nature editors, Andy Marshall and Juan-Carlos Lopez, have a conversation and a cocktail with experts in translational research and biomedicine
The Translational Mixer is hosted by Andy Marshall. The show has published 12 episodes to date.
Recent episodes include "Episode 12: CHDI's Robert Pacifici on new treatments for Huntington's toasted with a Boulevardier" (1 April 2025, 59 minutes), "Episode 11: William Pao on the hunt for life-changing drugs and a refreshing Hugo spritz" (2 February 2025, 54 minutes), and "Episode 10: Sebastian Giwa blazing a trail in organ storage/transplantation...and a flaming Sambuca" (1 January 2025, 54 minutes).
The Translational Mixer publishes roughly monthly, with episodes averaging 52 minutes across 12 episodes.
Booking probability for The Translational Mixer is 20%, and the host is rated Selective on guests. The Translational Mixer requires a Pod Score of 80 or higher. The Translational Mixer's contact route on record: public web form.
The strongest fits for The Translational Mixer are Scientific Research & Development. The Translational Mixer has a science audience.
Andy Marshall hosts The Translational Mixer, a science podcast with 12 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #3
<p>Send a text</p><p>Andy and JC get the lowdown from Robert Pacifici, CSO of CHDI Foundation, on the latest in Huntington's treatments from the recent 20th CHDI Therapeutics Conference in Palm Springs, California...
Episode #2
<p>Send a text</p><p>William Pao, CEO of Revelio Therapeutics, and former Chief Development Officer for Pfizer/Head of Roche pRED, sits down with JC and Andy to talk about his new book: 'Breakthrough: The quest for...
Episode #10
<p>Send a text</p><p>Sebastian Giwa, co-founder of the Organ Preservation Alliance and the Biostasis Research Institute and serial entrepreneur, talks to JC and Andy about the promise of organ storage research in...
The Translational Mixer
<p>Send a text</p><p>Andy and JC explore the murky world of cyberthreats to biopharma and biomanufacturing with Charles Fracchia, CEO of a Boston startup Black Mesa, currently in stealth mode and co-founder of BIO-ISAC...
Episode #8
<p>Send a text</p><p>https://bit.ly/3YxRltJ. Andrew Lo, Charles E. & Susan T. Harris Professor of Finance and director of the Laboratory for Financial Engineering at the MIT Sloan School of Management, gives JC and Andy...
Episode #7
<p>Send a text</p><p>Anne Wyllie, principal investigator at the Yale School of Public Health and pioneer of the Saliva Direct initiative, talks to JC and Andy about the potential of open and collaborative models to...
Episode #6
<p>Send a text</p><p>Veronique Kiermer, Chief Scientific Officer and Executive Editor at the Public Library of Science, talks about the myriad ways in which open science is changing the face of research and some of the...
Episode #5
<p>Send a text</p><p>Nathan Price, currently on leave from the Institute for Systems Biology in Seattle and Chief Scientific Officer at Thorne HealthTech, talks to JC and Andy about his data-driven approach to...
The Translational Mixer
<p>Send a text</p><p>UCSD's Dan Kaufman, an innovator in the field of induced pluripotent cell (iPSC)-derived natural killer cell therapies, talks to Andy and JC about the latest in allogeneic and autologous immune and...
Episode #3
<p>Send a text</p><p>UPenn's Kiran Musunuru, a human geneticist and practicing cardiologist who has pioneered the translation of gene- and base-editing approaches, talks to JC and Andy about the latest clinical results...
Episode #2
<p>Send a text</p><p>Scripps' Eric Topol is a visionary in the application of artificial intelligence to medicine. He has a wide-ranging conversation with JC and Andy about : </p><p>02:52 Multimodal AI is...
Episode #1
<p>Send a text</p><p>Pete Kirkpatrick, Chief Editor of Nature Reviews Drug Discovery, gives Andy and JC the lowdown on a Nature Conference on RNA therapeutics and what innovations he is seeing in the field of mRNA...
Recent guests on The Translational Mixer. Study who booked and why before you pitch.
Charles E. and Susan T. Harris Professor at MIT Sloan School of Management, MIT Sloan School of Management
Professor and Co-Director, Buck Institute for Research on Aging
Director of the Sanford Advanced Therapy Center, Meridian Compensation Partners, LLC
founder and director of the Scripps Research Translational Institute, professor of molecular medicine, executive vice president of Scripps Research, Scripps Research Translational Institute
PitchCentric classifies The Translational Mixer under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
